The fact that everything looks different doesn't mean that all has changed...
Biblio
Export 6 results:
[ Author
] Title Type Year Filters: First Letter Of Last Name is R [Clear All Filters]
. Bioactive VEGF-C from E. coli. Scientific Reports [Internet]. 2022;12(1). https://www.nature.com/articles/s41598-022-22960-0
Rauniyar et al. - 2022 - Bioactive VEGF-C from E. coli (4.19 MB)
Rauniyar et al. - 2022 - Bioactive VEGF-C from E. coli (4.19 MB). Expansion and collapse of VEGF diversity in major clades of the animal kingdom. Angiogenesis [Internet]. 2023;26(3):437 - 461. https://link.springer.com/10.1007/s10456-023-09874-9 Rauniyar et al. - 2023 - Expansion and collapse of VEGF diversity in major clades of the animal kingdom (3.59 MB)
Rauniyar et al. - 2023 - Expansion and collapse of VEGF diversity in major clades of the animal kingdom (3.59 MB). Biology of Vascular Endothelial Growth Factor C in the Morphogenesis of Lymphatic Vessels. Frontiers in Biotechnology and Bioengineering [Internet]. 2018;6. https://www.frontiersin.org/articles/10.3389/fbioe.2018.00007/full Rauniyar et al. - Biology of Vascular Endothelial Growth Factor C in the Morphogenesis of Lymphatic Vessels (4.42 MB)
Rauniyar et al. - Biology of Vascular Endothelial Growth Factor C in the Morphogenesis of Lymphatic Vessels (4.42 MB). VEGF-C: The evolutionary origin, activation, and potential as a drug target [Internet]. [Helsinki. Finland]: University of Helsinki; 2023. http://hdl.handle.net/10138/357923 Rauniyar - 2023 - VEGF-C: The evolutionary origin, activation, and potential as a drug target (3.09 MB)
Rauniyar - 2023 - VEGF-C: The evolutionary origin, activation, and potential as a drug target (3.09 MB). Targeting Bacterial and Human Levodopa Decarboxylases for Improved Drug Treatment of Parkinson's Disease: Discovery and Characterization of New Inhibitors. European Journal of Pharmaceutical Sciences [Internet]. 2025;:107133. https://authors.elsevier.com/sd/article/S0928-0987(25)00132-0 Reunanen et al. 2025 - Targeting Bacterial and Human Levodopa Decarboxylases for Improved Drug Treatment of Parkinson’s Disease (1.18 MB)
Reunanen et al. 2025 - Targeting Bacterial and Human Levodopa Decarboxylases for Improved Drug Treatment of Parkinson’s Disease (1.18 MB). Functional Dissection of the CCBE1 Protein: A Crucial Requirement for the Collagen Repeat Domain. Circ Res [Internet]. 2015;116(10):1660-1669. http://circres.ahajournals.org/content/116/10/1660.long